CONMED CorporationCNMDNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
2.68%
↓ 66% below average
Average (9y)
7.87%
Historical baseline
Range
High:30.58%
Low:-10.97%
CAGR
-18.9%
Structural decline
| Period | Value |
|---|---|
| 2025 | 2.68% |
| 2024 | 3.47% |
| 2023 | 11.56% |
| 2022 | 8.23% |
| 2021 | 7.64% |
| 2020 | -10.97% |
| 2019 | 7.76% |
| 2018 | 30.58% |
| 2017 | 0.16% |
| 2016 | 17.56% |